. . "CZ - \u010Cesk\u00E1 republika" . . "I" . "1211-9059" . . "The diabetic macular edema - new possibilities of the treatment"@en . . "V \u010Dl\u00E1nku jsou shrnuty liter\u00E1rn\u00ED \u00FAdaje o nov\u00FDch mo\u017Enostech l\u00E9\u010Dby diabetick\u00E9ho makul\u00E1rn\u00EDho ed\u00E9mu. P\u0159i srovn\u00E1n\u00ED intravitre\u00E1ln\u00ED aplikace triamcinolonu oproti fotokoagulaci laserem byl prok\u00E1z\u00E1n lep\u0161\u00ED efekt laserov\u00E9 l\u00E9\u010Dby p\u0159i jejich men\u0161\u00EDch vedlej\u0161\u00EDch \u00FA\u010Dinc\u00EDch. P\u0159i kombinovan\u00E9 l\u00E9\u010Db\u011B triamcinolonem s fotokoagulac\u00ED laserem ve srovn\u00E1n\u00ED s monoterapi\u00ED laserem nebyl prok\u00E1z\u00E1n lep\u0161\u00ED \u00FA\u010Dinek kombinovan\u00E9 l\u00E9\u010Dby. Intravitre\u00E1ln\u00ED implant\u00E1t uvol\u0148uj\u00EDc\u00ED fluocinolon acetonid v\u00FDznamn\u011B zlep\u0161oval nejl\u00E9pe korigovanou zrakovou ostrost (NKZO), ale vedl k progresi katarakty a elevaci nitroo\u010Dn\u00ED tenze. Intravitre\u00E1ln\u011B pod\u00E1van\u00FD ranibizumab v\u00FDznamn\u011B zlep\u0161oval NKZO v monoterapii i v kombinaci s fotokoagulac\u00ED s\u00EDtnice laserem. Intravitre\u00E1ln\u011B pod\u00E1van\u00FD bevacizumab v\u00FDznamn\u011B zlep\u0161oval NKZO, jeho u\u017Eit\u00ED je v\u0161ak pouze off - label. V kone\u010Dn\u00E9 f\u00E1zi klinick\u00FDch zkou\u0161ek je aflibercept." . "Diabetick\u00FD makul\u00E1rn\u00ED ed\u00E9m - nov\u00E9 mo\u017Enosti l\u00E9\u010Dby" . . "V \u010Dl\u00E1nku jsou shrnuty liter\u00E1rn\u00ED \u00FAdaje o nov\u00FDch mo\u017Enostech l\u00E9\u010Dby diabetick\u00E9ho makul\u00E1rn\u00EDho ed\u00E9mu. P\u0159i srovn\u00E1n\u00ED intravitre\u00E1ln\u00ED aplikace triamcinolonu oproti fotokoagulaci laserem byl prok\u00E1z\u00E1n lep\u0161\u00ED efekt laserov\u00E9 l\u00E9\u010Dby p\u0159i jejich men\u0161\u00EDch vedlej\u0161\u00EDch \u00FA\u010Dinc\u00EDch. P\u0159i kombinovan\u00E9 l\u00E9\u010Db\u011B triamcinolonem s fotokoagulac\u00ED laserem ve srovn\u00E1n\u00ED s monoterapi\u00ED laserem nebyl prok\u00E1z\u00E1n lep\u0161\u00ED \u00FA\u010Dinek kombinovan\u00E9 l\u00E9\u010Dby. Intravitre\u00E1ln\u00ED implant\u00E1t uvol\u0148uj\u00EDc\u00ED fluocinolon acetonid v\u00FDznamn\u011B zlep\u0161oval nejl\u00E9pe korigovanou zrakovou ostrost (NKZO), ale vedl k progresi katarakty a elevaci nitroo\u010Dn\u00ED tenze. Intravitre\u00E1ln\u011B pod\u00E1van\u00FD ranibizumab v\u00FDznamn\u011B zlep\u0161oval NKZO v monoterapii i v kombinaci s fotokoagulac\u00ED s\u00EDtnice laserem. Intravitre\u00E1ln\u011B pod\u00E1van\u00FD bevacizumab v\u00FDznamn\u011B zlep\u0161oval NKZO, jeho u\u017Eit\u00ED je v\u0161ak pouze off - label. V kone\u010Dn\u00E9 f\u00E1zi klinick\u00FDch zkou\u0161ek je aflibercept."@cs . "Studni\u010Dka, Jan" . "130919" . . "\u010Cesk\u00E1 a slovensk\u00E1 oftalmologie" . "Diabetick\u00FD makul\u00E1rn\u00ED ed\u00E9m - nov\u00E9 mo\u017Enosti l\u00E9\u010Dby" . . "[9C241FC8F516]" . "Diabetick\u00FD makul\u00E1rn\u00ED ed\u00E9m - nov\u00E9 mo\u017Enosti l\u00E9\u010Dby"@cs . "2" . "aflibercept; bevacizumab; ranibizumab; fluocinolon acetonide; triamcinolon; laser photocoagulation"@en . "1"^^ . "The article summarizes data from the literature about new possibilities of the diabetic macular edema treatment. Comparing intravitreal aplication of triamcinolone and laser photocoagulation, the better effect of the laser treatment with its lower side effects was proven. In combined treatment of triamcinolone and laser photocoagulation comparing with the laser monotherapy, no better effect of the combined therapy was proven. The intravitreal implant releasing fluocinolone acetonide significantly improved the bestcorrected visual acuity (BCVA), but caused cataract progression and elevation of the intraocular pressure. Intravitreal application of ranibizumab significantly improved BCVA in the monotherapy, and in the combination with the retinal laser photocoagulation did as well. Intravitreal application of bevacizumab significantly improved BCVA, but its use is off-label only. Aflibercept is in the final stage of clinical trails."@en . "RIV/00179906:_____/12:10128044!RIV13-MZ0-00179906" . "1"^^ . . . "Diabetick\u00FD makul\u00E1rn\u00ED ed\u00E9m - nov\u00E9 mo\u017Enosti l\u00E9\u010Dby"@cs . . "3"^^ . . . "RIV/00179906:_____/12:10128044" . "68" . . "The diabetic macular edema - new possibilities of the treatment"@en . . . . .